SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-331994
Filing Date
2021-11-17
Accepted
2021-11-17 09:04:04
Documents
18
Period of Report
2021-11-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d222547d8k.htm   iXBRL 8-K 32409
2 EX-1.1 d222547dex11.htm EX-1.1 176039
3 EX-5.1 d222547dex51.htm EX-5.1 10421
4 EX-99.1 d222547dex991.htm EX-99.1 8137
8 GRAPHIC g222547g1117005615466.jpg GRAPHIC 3627
9 GRAPHIC g222547g1117010402621.jpg GRAPHIC 1584
10 GRAPHIC g222547g12h23.jpg GRAPHIC 2086
  Complete submission text file 0001193125-21-331994.txt   413225

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA apls-20211115.xsd EX-101.SCH 2889
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE apls-20211115_lab.xml EX-101.LAB 17374
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apls-20211115_pre.xml EX-101.PRE 10951
11 EXTRACTED XBRL INSTANCE DOCUMENT d222547d8k_htm.xml XML 3208
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38276 | Film No.: 211418572
SIC: 2834 Pharmaceutical Preparations